ALDH2 belongs to the acetaldehyde dehydrogenase family, and its reduction not only induces proliferation and stem cell properties of LUAD cells but also may induce DNA damage, which will promote tumor recurrence, drug resistance, and metastasis, leading to poor prognosis of LUAD (Li et al., 2019). This evidence concerns the gene ALDH2 and neoplasm.